Sign In
Get Started →
Pawel Przewiezlikowski
Chief Executive Officer at Ryvu Therapeutics
Summary
Pawel Przewiezlikowski is the Chief Executive Officer and Co-Founder of Ryvu Therapeutics, a clinical stage biopharmaceutical company based in Kraków, Poland. With a team of 150 scientists, including 80 Ph.Ds, Ryvu Therapeutics focuses on developing innovative small molecule therapies targeting precision oncology. The company, formerly known as Selvita, is listed on the Warsaw Stock Exchange and specializes in addressing the clinical limitations of current cancer treatments through its deep scientific knowledge and high throughput discovery platform.
This public profile is provided courtesy of Clay. All information found here is in the public domain.
This public profile is provided courtesy of Clay. All information found here is in the public domain.